Clinical trial

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

Recruiting now · Not applicable · 1 countries · Registry ID NCT05494138

Recruiting nowNot applicableObservational

What this study is about

The purpose of this study is to establish a prospective cohort. From registration to the 5th year, basic investigation, specific examinations for cardiovascular and metabolic disease, basic blood tests, collection of human material samples, and clinical event follow-up are conducted yearly. The obese group will be examined yearly, and telephone follow-up will be conducted if necessary. The control group will participate in the baseline survey once enrollment and clinical event follow-up by phone will be conducted annually thereafter. From the 6th year, only clinical event follow-up will be conducted.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age19 Years to Not listed
SexAll
Healthy volunteersAccepted
ConditionObesity

Full registry criteria

Inclusion criteria for the obese group 1. Adults 19 years of age or older 2. Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, \[BMI ≥ 30 kg/m2, including 10% or more\]) Inclusion criteria for the control group 1. Adults 19 years of age or older 2. Those with BMI 18.5\~24.9 kg/m2 Exclusion criteria for the obese group 1. Serious non-cardiovascular disease with life expectancy less than 6 months 2. Pregnant or suspected of being pregnant or are lactating 3. Patients within 3 months of organ transplantation 4. Patients currently being treated for acute transplant rejection 5. Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months 6. Patients with acute cerebral infarction within 6 months of being hospitalized and discharged 7. Type 1 Diabetes 8. Patients taking steroids, female hormones 9. Those who have difficulty using smartphones Exclusion criteria for the control group 1. Serious non-cardiovascular disease with life expectancy less than 6 months 2. Pregnant or suspected of being pregnant or are lactating 3. Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia 4. Within 5 years of diagnosis of malignant tumor 5. Those who have difficulty using smartphones

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Differences of nutriomics according to obesity phenotypesAt five years of study

Cross-sectional analysis of nutriomics of normal control group and obese patients

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Yonsei University Health System, Severance Hospital🇰🇷 Seoul, South Korea
Sungha ParkContact